The largest database of trusted experimental protocols

8 protocols using bhk 21 wi 2 cells

1

Evaluating Viral Entry Inhibitors Using Pseudotyped VSV

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vesicular Stomatitis Virus (VSV) pseudotyped with spike (S) proteins of MERS and SARS-CoV-2 were generated according to a published protocol45 (link). Briefly, BHK-21/WI-2 cells (Kerafast, MA) transfected to express the S proteins were inoculated with VSV-G pseudotyped ΔG-luciferase VSV (Kerafast, MA). After a 2-hour incubation at 37 °C, the inoculum was removed and DMEM supplemented with 5 % FBS, 50 U/mL penicillin, and 50 μg/mL streptomycin were added back to cells. Pseudotyped particles were collected 24 h post-inoculation, then centrifuged at 1,320×g to remove cell debris and stored at −80 °C until use. To determine the effect of the selected compounds on viral entry, Vero E6 cells were treated with each compound at a concentration of 2.5 μM for 1 h prior to inoculation with respective pseudotyped VSV. After 2 hours inoculation in the presence of the compounds, the inoculum was removed, and fresh medium was added to cells for further culture. The activity of firefly luciferase as a readout of infected cells was measured using the bright-Glo™ luciferase assay (Promega) for quantitative determination at 16 hours post-transduction.
+ Open protocol
+ Expand
2

Cell Culture and Transfection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T human fetal kidney and HeLa human cervix epithelial cells were obtained from ATCC (cat. nos. CRL-3216 and CCL-2). Both cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco) supplemented with fetal bovine serum (FBS) and antibiotic 1% penicillin/streptomycin. BHK-21-/WI-2 cells (Kerafast, EH1011, Boston, MA) were grown in DMEM supplemented with 5% FBS and 1% penicillin/streptomycin. All cells were incubated in a 37°C incubator under 5% CO2 atmosphere.
For most experiments, 96-well plates were used. For mRNA stability, a 24-well plate was used. Cells resuspended (in DMEM plus 10% FBS) were seeded (3–4 × 104 cells/well for a 96-well plate or 1–2 × 105 cells/well for a 24-well plate) the night before the transfections. For transfections, Transporter 5 transfection reagent (TP5) (Polysciences, Warrington, PA, cat. no. 26008) was used at 1 to 4 ratios of DNA/reagent. Typically, 50–100 ng plasmid DNA per well for 96-well plates was mixed with 0.2–0.4 μL TP5 in 0.9% NaCl solution and incubated at room temperature for 20 min. The transfection reagent and DNA solution were mixed again and added to each well dropwise. The transfections were incubated at 37°C in 5% CO2 overnight (16–18 h), and the medium was replaced with DMEM plus 10% FBS.
+ Open protocol
+ Expand
3

SARS-CoV-2 S Pseudotype Neutralization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Codon-optimized full-length spike (S) protein of the original Wuhan-Hu-1 isolate with D614G mutation (D614G) was cloned into a pCAGGS vector. This codon-optimized D614G vector was used as a template for site-directed mutagenesis to incorporate the S variants, listed in Table 1. To make SARS-CoV-2 full-length S-pseudotyped recombinant vesicular stomatitis virus ΔG (VSVΔG)-firefly luciferase virus, BHK-21/WI-2 cells (Kerafast) were transfected with the S expression plasmid and subsequently infected with VSVΔG-firefly luciferase as previously described (11 (link)). For the neutralization assay, serially diluted serum samples were mixed with pseudovirus and incubated at 37°C for 45 min. The virus-serum mix was subsequently used to infect A549-hACE2-TMPRSS2 cells (12 (link)) for 18 h at 37°C before addition of ONE-Glo reagent (Promega) for measurement of the luciferase signal by relative luminescence units (RLUs). The percentage of neutralization was calculated based on the RLUs of the virus-only control and subsequently analyzed using the four-parameter logistic curve in Prism v.8 (GraphPad Software, Inc.).
+ Open protocol
+ Expand
4

Pseudotyped VSV Entry Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vesicular Stomatitis Virus (VSV) pseudotyped with spike proteins of MERS-CoV, SARS-CoV-1, and SARS-CoV-2 were generated as previously reported with some modifications45 (link). Briefly, BHK-21/WI-2 cells (Kerafast, MA) overexpressing the spike proteins were inoculated with VSV-G pseudotyped AG-luciferase VSV (Kerafast, MA). After 2 h inoculation at 37°C, the inoculum was removed and cells were refed with DMEM supplemented with 5% FBS and VSV-G antibody (I1, mouse hybridoma supernatant from CRL-2700; ATCC). Pseudotyped particles were collected at 24 h post-inoculation, then centrifuged at 1,320 × g to remove cell debris and stored at −80°C until use.
To determine the effect of the compounds on viral entry, VeroE6 cells were treated with clofazimine at a concentration of 2.5 μM for 1 h prior to inoculation with respective pseudotyped VSV. After 2 h inoculation in the presence of the compounds, the inoculum was removed and cells were refed with fresh medium for further culture. The activity of firefly luciferase was measured using bright-Glo™ luciferase assay (Promega) for quantitative determination at 16 h post-transduction.
+ Open protocol
+ Expand
5

Evaluating Viral Entry Inhibitors Using Pseudotyped VSV

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vesicular Stomatitis Virus (VSV) pseudotyped with spike (S) proteins of MERS and SARS-CoV-2 were generated according to a published protocol45 (link). Briefly, BHK-21/WI-2 cells (Kerafast, MA) transfected to express the S proteins were inoculated with VSV-G pseudotyped ΔG-luciferase VSV (Kerafast, MA). After a 2-hour incubation at 37 °C, the inoculum was removed and DMEM supplemented with 5 % FBS, 50 U/mL penicillin, and 50 μg/mL streptomycin were added back to cells. Pseudotyped particles were collected 24 h post-inoculation, then centrifuged at 1,320×g to remove cell debris and stored at −80 °C until use. To determine the effect of the selected compounds on viral entry, Vero E6 cells were treated with each compound at a concentration of 2.5 μM for 1 h prior to inoculation with respective pseudotyped VSV. After 2 hours inoculation in the presence of the compounds, the inoculum was removed, and fresh medium was added to cells for further culture. The activity of firefly luciferase as a readout of infected cells was measured using the bright-Glo™ luciferase assay (Promega) for quantitative determination at 16 hours post-transduction.
+ Open protocol
+ Expand
6

Generation of SARS-CoV-2 S Pseudotyped VSV

Check if the same lab product or an alternative is used in the 5 most similar protocols
VSV pseudotyped with spike (S) protein of SARS-CoV-2 was generated according to a published protocol (Whitt, 2010 (link)). Briefly, BHK-21/WI-2 cells (Kerafast, MA) transfected with SARS-CoV-2 S protein were inoculated with VSV-G pseudotyped ΔG-luciferase VSV (Kerafast, MA). After a 2 hour incubation at 37°C, the inoculum was removed and cells were treated with DMEM supplemented with 5% FBS, 50 U/mL penicillin, and 50 μg/mL streptomycin. Pseudotyped particles were collected 24 h post-inoculation, then centrifuged at 1,320 × g to remove cell debris and stored at −80°C until use.
+ Open protocol
+ Expand
7

SARS-CoV-2 Spike Protein Binding Assay with Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human ACE2 (hACE2) with the Fc region of mouse IgG1 at the C-terminus (hACE2-mFc), SARS-CoV-2 S with poly-His tag at the C-terminus, including full-length S, S1, S2, and RBD, were purchased from Sino Biological (Wayne, PA, USA). HEK293T-hACE2 (NR-52511, BEI Resources, NIAID, NIH), A549-hACE2 (NR-53522, BEI Resources, NIAID, NIH), Hela-hACE2 cells (Luo, unpublished) and Vero E6 (CRL-1586, ATCC, Manassas, VA, USA) were maintained in DMEM (GIBCO, NY, USA) supplemented with 10% FBS (GIBCO), penicillin (100 IU/mL), streptomycin (100 μg/mL). BHK-21-/WI-2 cells (EH1011, Kerafast, Boston, MA, USA) were grown in DMEM supplemented with 5% FBS. Calu-3 cells (HTB-5, ATCC, Manassas, VA, USA) were maintained in Collagen type I (Corning) coated plate or flask in DMEM supplemented with 5% FBS. HCT-8 cells (CCL-244, ATCC, Manassas, VA, USA) were cultured in RPMI (GIBCO, NY, USA) supplemented with 10% horse serum (GIBCO). All the cells were cultured in a 5% CO2 environment at 37 °C and passaged every 2–3 days. The green tea catechins with a purity of > 95% (EGCG, ECG, EGC and EC) were purchased from Sigma-Aldrich (St. Louis, MO, USA), and prepared for the stock solution at 10 mM in endotoxin-free water. Firefly luciferase substrate was from Promega (Madison, WI, USA).
+ Open protocol
+ Expand
8

Generating SARS-CoV-2 Spike Pseudoviruses

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the generation of the spike protein bearing VSV-based pseudoviruses, a pCAGGS vector was used to clone the spike protein sequence, with 18 codons at the C-terminal end of the sequence deleted to improve packaging efficiency. Mutations were induced using NEBuilder HiFi cloning, and sequencing was performed to ensure the required mutations. BHK-21/WI-2 cells (Kerafast, catalog #: EH1011) were transfected with the spike-expression plasmid and subsequently infected with rVSV-firefly-luciferase (Kerafast, catalog #: EH1020-PM) to yield VSV-pseudovirus containing a supernatant that was then collected, centrifuged at 500× g for 5 min, and then filtered with a 0.45 μm polyethersulfone membrane [21 (link)]. The variant mutation profiles were designed to match with the variants described by the WHO and online bioinformatics references [22 ,23 ].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!